Xiaojun Zhu
Hohhot, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
ALOX5 mediates sunitinib resistance in renal cell carcinoma by reprogramming lipid metabolism through the p38/ERK/PPARα axis.
Journal: International immunopharmacology
Published: April 14, 2026
Experimental study of extracellular vesicle-small intestine submucosa novel biological composite for urethral stricture repair and reconstruction.
Journal: Bio-medical materials and engineering
Published: February 20, 2025
Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 30, 2024
Unveiling the functions of five recently characterized lncRNAs in cancer progression.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 29, 2024
CircCNOT6L modulates alternative splicing of SLC7A11 via splicing factor SRSF2 to confer ferroptosis resistance and promote metastasis in prostate cancer.
Journal: Experimental & molecular medicine
Published: February 19, 2024
AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A Modification.
Journal: Research (Washington, D.C.)
Published: June 18, 2023
The complete mitochondrial genome of Brachyrhynchus triangulus (Hemiptera: Aradoidea: Aradidae).
Journal: Mitochondrial DNA. Part B, Resources
Published: April 24, 2023
Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.
Journal: Toxicology and applied pharmacology
Published: January 06, 2022
5-Aza-2'-Deoxycytidine and CDDP Synergistically Induce Apoptosis in Renal Carcinoma Cells via Enhancing the APAF-1 Activity.
Journal: Clinical laboratory
Published: February 18, 2016
COP1 is downregulated in renal cell carcinoma (RCC) and inhibits the migration of RCC ACHN cells in vitro.
Journal: Molecular medicine reports
Published: May 26, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026